Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts

International Journal of Cancer

Volumn 67, Issue 3, 1996, Pages 372-378

  Lee, Jungeun ^a   Siemann, Dietmar W ^b   Koch, Cameron J ^c   Lord, Edith M ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY;

ANIMAL CELL; ANTIBODY DETECTION; ARTICLE; CANCER RADIOTHERAPY; CELL SURVIVAL; CLONOGENESIS; HYPOXIA; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIVITY; SARCOMA; TISSUE OXYGENATION; TUMOR BLOOD FLOW;

ANEMIA; ANIMALS; ANTIBODIES, MONOCLONAL; CARBON DIOXIDE; CELL HYPOXIA; CELL SURVIVAL; ETANIDAZOLE; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HYDRALAZINE; HYDROCARBONS, FLUORINATED; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; OXYGEN; PHENYLHYDRAZINES; RADIOBIOLOGY; SARCOMA, EXPERIMENTAL; VASODILATOR AGENTS;

EID: 0343530603     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960729)67:3<372::AID-IJC11>3.0.CO;2-A     Document Type: Article

References (20)

1. CHAPMAN, D.J., BAER, K. and LEE, J., Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. Cancer Res., 47, 1523-1528 (1983).
2. EVANS, S.M., JOINER, B., JENKINS, W.T., LAUGHLIN, K.M., LORD, E.M. and KOCH, C.J., Identification of hypoxia in cells and tissues of epigastric 9L rat glioma using EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]. Brit. J. Cancer, 72, 875-882 (1995).
3. FENTON, B.M., KIANI, M.F. and SIEMANN, D.W., Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int. J. Radiat. Oncol. Biol. Phys., 33, 365-373 (1995).
4. FRANKO, A.J., KOCH, C.J., GARRECHT, B.M., SHARPLIN, J. and HUGHES, D., Oxygen dependence of binding of misonidazole to rodent and human tumors in vitro. Cancer Res., 52, 1-7 (1987).
5. HODGKISS, R.J., JONES, G., LONG, A., PARRICK, J., SMITH, K.A., STRATFORD, M.R.L. and WILSON, G.D., Flow cytometric evaluation of hypoxic cells in solid experimental tumours using fluorescence immunodetection. Brit. J. Cancer, 63, 119-125 (1991).
6. HORSMAN, M.R., KHALIL, A.A., NORDSMARK, M., SIEMANN, D.W., HILL, S.A., LYNCH, E.M., CHAPLIN, D.J., STERN, S., THOMAS, C.D., GUICHARD, M., GRAU, C. and OVERGAARD, J., The use of oxygen electrodes to predict radiobiological hypoxia in tumours. In: P. Vaupel, D.K. Kelleher and M. Guenderoth (eds.), Tumor oxygenation, pp. 49-57, G. Fischer, Stuttgart. (1994).
7. KALLMAN, R.F., SILINI, G. and VAN PUTTEN, L.M., Factors influencing the quantitative estimation of the in vivo survival of cells from solid tumors. J. nat. Cancer Inst., 39, 539-549 (1967).
8. KOCH, C.J., EVANS, S.M. and LORD, E.M., Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: analysis of drug adducts by fluorescent antibodies vs. bound radioactivity. Brit. J. Cancer, 72, 869-875 (1995).
9. LORD, E.M., HARWELL, L. and KOCH, C.J., Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts. Cancer Res., 53, 5721-5726 (1993).
10. OVERGAARD, J., HANSEN, H.S., JORGENSEN, K. and HANSEN, M.H., Primary radiotherapy of larynx and pharynx carcinomas - an analysis of some factors influencing local control and survival. Int. J. Radiat. Oncol. Biol. Phys., 12, 515-521 (1986).
11. PARLIAMENT, M.B., CHAPMAN, J.D., URTASUN, R.C., MCEWAN, A.J., GOLBERG, L., MERCER, J.R., MANNAN, R.H. and WIEBE, L.I., Noninvasive assessment of human tumour hypoxia with I-iodoazomycin arabinoside: preliminary report of a clinical study. Brit. J. Cancer, 65, 90-95 (1992).
12. RALEIGH, J.A., FRANKO, A.J., TREIBER, E.O., LUNT, H.A. and ALLEN, P.S., Covalent binding of a fluorinated 2-nitroimidazole to EMT-6 tumours in BALB/c mice: detection by F-19 nuclear magnetic resonance at 2.35 T. Int. J. Radiat. Oncol. Biol. Phys., 10, 1337-1340 (1984).
13. RALEIGH, J.A., MILLER, G.G., FRANKO, A.J., KOCH, C.J., FUCIARELLI, A.F. and KELLEY, D.A., Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Brit. J. Cancer, 56, 395-400 (1987).
14. RASEY, J.S., GRUNBAUM, Z., MAGEE, S., NELSON, N.J., OLIVE, P.L., DURAND, R.E. and KROHN, K.A., Characterization of radiolabelled fluoromisonidazole as a probe for hypoxic cells. Rad. Res., 111, 292-304 (1987).
15. SIEMANN, D.W., Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine. Brit. J. Cancer, 62, 348-353 (1990).
16. SIEMANN, D.W., ALLIET, K. and MACLER, L.M., Manipulation in the oxygen transport capacity of blood as a means of sensitizing tumors to radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 16, 1169-1172 (1989).
17. SIEMANN, D.W., CHAPLIN, D.J. and HORSMAN, M.R., The radiation response of KHT sarcomas following nicotinamide treatment and carbogen breathing. Radiother. Oncol., 31, 117-122 (1994).
18. SIEMANN, D.W. and KENG, P.C., Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas I. Centrifugal elutriation. Brit. J. Cancer, 55, 33-36 (1987).
19. STONE, H.B., BROWN, M.J., PHILLIPS, T.L. and SUTHERLAND, R.M., Oxygen in human tumors: correlations between methods of measurement and response to therapy. Rad. Res., 136, 422-434 (1993).
20. WOODS, M.L., KOCH, C.J. and LORD, E.M., Detection of individual hypoxic cells in multicellular spheroids by flow cytometry using the 2-nitroimidazole, EF5 and monoclonal antibodies. Int. J. Radiat. Oncol. Biol. Phys., 34, 93-101 (1996).